While DTC pharmacy models offer convenience, they may create cost, access, and guidance barriers for the "working poor."
T. Joseph Mattingly II, PhD, PharmD, MBA
Advertisement
Articles by T. Joseph Mattingly II, PhD, PharmD, MBA
Experts explain that DTC models could improve medication adherence through convenience and incentives, but higher costs may limit their effectiveness.
The recent reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) comes with an expanded mandate to study the economic impacts of treatments presenting new opportunities for the value assessment research community.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
3
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5